A.M. Tomkiel et al. / Steroids 82 (2014) 60–67
63
2.2.6. Other cholesterol derivatives
2.2.6.1. Cholest-5-en-3b-yl thiocyanate (7). White crystals, mp 126–
128 °C (acetone); Rf = 0.56 (hexane-AcOEt 95:5); IR,
NMR (ppm), d: 5.43 (m, 1H, H-6), 3.10 (m, 1H, H-3 ), 1.04 (s, 3H, H-
(C), 109.8 (C), 84.6 (CH), 81.3 (CH), 79.4 (CH), 78.9 (CH), 62.4
(CH2), 56.79 (CH), 56.77 (CH), 56.2 (CH), 50.32 (CH), 50.27 (CH),
48.4 (CH), 44.6 (CH), 44.1 (CH), 42.3 (C), 40.6 (CH2), 40.2 (CH2),
39.8 (CH2), 39.7 (CH2), 39.5 (CH2), 36.92 (C), 36.89 (C), 36.2
(CH2), 35.8 (CH), 31.91 (CH2), 31.86 (CH2), 29.4 (CH2), 29.3 (CH2),
28.2 (CH2), 28.0 (CH), 27.15 (CH3), 27.14 (CH3), 27.1 (CH3), 26.9
(CH3), 24.3 (CH2), 23.8 (CH2), 22.8 (CH3), 22.5 (CH3), 20.9 (CH2),
19.4 (CH3), 19.3 (CH3), 18.7 (CH3), 11.9 (CH3); ESI MS, m/z: 1069
[(M+Na)+, 100%]; HRMS (ESI): m/z calcd for (C66H110O5S2+Na)+:
1069.7693 (M+Na)+; found 1069.7679.
m
max: 2154; 1H
a
19), 0.92 (d, 3H, J = 6.5 Hz, H-21), 0.878 (d, 3H, J = 6.6 Hz, H-26 or
H-27), 0.873 (d, 3H, J = 6.6 Hz, H-26 or H-27), 0.69 (s, 3H, H-18);
13C NMR, d: 140.0 (C), 123.1 (CH), 111.2 (C), 56.7 (CH), 56.2 (CH),
50.1 (CH), 48.1 (CH), 42.3 (C), 39.7 (CH2), 39.7 (CH2), 39.5 (CH2),
39.4 (CH2), 36.5 (C), 36.2 (CH2), 35.8 (CH), 31.8 (CH2), 31.7 (CH),
30.0 (CH2), 28.2 (CH2), 28.0 (CH), 24.2 (CH2), 23.8 (CH2), 22.8
(CH3), 22.5 (CH3), 20.9 (CH2), 19.2 (CH3), 18.7 (CH3), 11.8 (CH3);
ESI MS, m/z: 877 [(2ꢁM+Na)+, 75%], 482 [(M+MeOH+Na)+, 100%],
450 [(M+Na)+, 95%]; HRMS (ESI): m/z calcd for (C28H45NS+Na)+:
450.3171 (M+Na)+; found 450.3165.
2.2.8.2.
3b-O-(3,4-O-isopropylidene-a-D-galactopyranos-6-yl)-cho-
lest-5-ene (24). Colorless crystals, mp 145–148 °C (CH2Cl2/hex-
ane); Rf = 0.30 (hexane-AcOEt 9:1); IR,
mmax: 3550, 1083, 1064;
1H NMR (ppm), d: 5.37 (s, 1H, H-10), 5.35 (m, 1H, H-6), 4.50 (dd,
1H, J1 = 5.8 Hz, J2 = 5.5 Hz, H-50), 4.46 (dd, 1H, J1 = 7.0 Hz,
J2 = 5.8 Hz, H-40), 4.15 (d, 1H, J = 7.0 Hz, H-30), 4.10 (d, 1H,
J = 7.6 Hz, H-60a), 3.62 (s, 1H, H-20), 3.58 (dd, 1H, J1 = 7.6 Hz,
2.2.6.2. Cholest-5-ene-3b-thiol (8). White crystals, mp 96–97 °C
(hexane/AcOEt); Rf = 0.41 (hexane); IR, mmax
(ppm), d: 5.33 (m, 1H, H-6), 2.70 (m, 1H, H-3
:
a
1467; 1H NMR
), 1.01 (s, 3H, H-
J2 = 5.5 Hz, H-60b), 3.35 (m, 1H, H-3
a), 1.54 (s, 3H, H-isopropyli-
19), 0.93 (d, 3H, J = 6.5 Hz, H-21), 0.881 (d, 3H, J = 6.6 Hz, H-26 or
H-27), 0.876 (d, 3H, J = 6.6 Hz, H-26 or H-27), 0.69 (s, 3H, H-18);
13C NMR, d: 141.9 (C), 121.0 (CH), 56.7 (CH), 56.2 (CH), 50.2 (CH),
44.2 (CH2), 42.3 (C), 39.9 (CH2), 39.8 (CH2), 39.5 (CH2), 39.4 (CH),
36.3 (C), 36.2 (CH2), 35.8 (CH), 34.1 (CH2), 31.788 (CH), 31.787
(CH2), 28.2 (CH2), 28.0 (CH), 24.3 (CH2), 23.8 (CH2), 22.8 (CH3),
22.6 (CH3), 20.9 (CH2), 19.3 (CH3), 18.7 (CH3), 11.8 (CH3); ESI MS
(negative ion mode), m/z: 401 [(MꢂH)ꢂ, 100%].
dene), 1.36 (s, 3H, H-isopropylidene), 1.01 (s, 3H, H-19), 0.93 (d,
3H, J = 6.5 Hz, H-21), 0.880 (d, 3H, J = 6.6 Hz, H-26 or H-27),
0.876 (d, 3H, J = 6.6 Hz, H-26 or H-27), 0.67 (s, 3H, H-18); 13C
NMR (ppm), d: 140.4 (C), 122.1 (CH), 108.4 (C), 100.7 (CH), 79.4
(CH), 75.5 (CH), 75.4 (CH), 72.0 (CH), 69.4 (CH), 63.1 (CH2), 56.8
(CH), 56.2 (CH), 50.2 (CH), 42.3 (C), 39.8 (CH2), 39.5 (CH2), 39.2
(CH2), 37.2 (CH2), 36.8 (C), 36.2 (CH2), 35.8 (CH), 31.94 (CH2),
31.90 (CH), 29.0 (CH2), 28.2 (CH2), 28.0 (CH), 25.8 (CH3), 24.4
(CH3), 24.3 (CH2), 23.8 (CH2), 22.8 (CH3), 22.6 (CH3), 21.1 (CH2),
19.4 (CH3), 18.7 (CH3), 11.9 (CH3); ESI MS, m/z: 593 [(MꢂH2O+Na)+,
100%]; elemental analysis calcd (%) for C36H60O6: C 73.43, H 10.27;
found: C 73.36, H 10.25.
2.2.7. Electrolysis of cholesteryl diphenylphosphates (15) in the
presence of 1,2:3,4-di-O-isopropylidene-
Cholesteryl diphenylphosphate (15; 185 mg; 0.30 mmol)
and 1,2:3,4-di-O-isopropylidene- -galactopyranose (96 mg; 0.37
D-galactopyranose
D
mmol) were dissolved in a 0.1 M solution of tetrabutylammonium
tetrafluoroborate in dichloromethane (3.5 mL) and introduced into
the anodic compartment together with a 0.3 g 3A molecular sieve
to eliminate traces of water. The same supporting electrolyte was
placed in the cathodic compartment with an anionite (1 g, Dowex
2 ꢁ 8, 200–400 mesh, perchlorate form) added to eliminate chlo-
ride ions from forming by the reduction of dichloromethane. A pre-
parative electrolysis was carried out in a divided H-cell in which
the cathodic and anodic compartments (3.5 mL of electrolytes
each) were separated by a glass frit under galvanostatic conditions.
A direct current 7.5 mA was run for 3600 s. A platinum mesh was
used as a cathode and a platinum plate (2 ꢁ 1.5 cm) was used as
an anode. Ag/0.1 M AgNO3 in an acetonitrile electrode was used
as a reference. When the electrolysis was completed the solvent
was removed from the reaction mixture and the products were
separated by silica gel column chromatography. The hexane–ethyl
acetate (94:6) elution afforded unreacted substrate (15; 22 mg;
2.2.8.3. p-Di(cholest-5-en-3b-yloxy)benzene (25). Colorless crystals,
mp 223–226 °C (CH2Cl2/hexane); Rf = 0.41 (hexane-AcOEt 95:5);
IR,
m
max: 1602, 1503, 1033, 1018, 830; 1H NMR (ppm), d: 6.82 (s,
4H, H-Ar), 5.38 (m, 2H, H-6), 3.99 (m, 2H, H-3
a), 1.06 (s, 6H, H-
19), 0.93 (d, 6H, J = 6.5 Hz, H-21), 0.884 (d, 6H, J = 6.6 Hz, H-26 or
H-27), 0.879 (d, 6H, J = 6.6 Hz, H-26 or H-27), 0.70 (s, 3H, H-18);
13C NMR (ppm), d: 151.9 (C), 140.5 (C), 122.1 (CH), 117.4 (CH),
78.2 (CH), 56.8 (CH), 56.2 (CH), 50.2 (CH), 42.3 (C), 39.8 (CH2),
39.5 (CH2), 38.9 (CH2), 37.2 (CH2), 36.9 (C), 36.2 (CH2), 35.8 (CH),
32.0 (CH2), 31.9 (CH), 28.4 (CH2), 28.2 (CH2), 28.0 (CH), 24.3
(CH2), 23.8 (CH2), 22.8 (CH3), 22.6 (CH3), 21.1 (CH2), 19.4 (CH3),
18.7 (CH3), 11.9 (CH3); EI MS, m/z: 846 (M+, 3%), 369 [(cholest-5-
en-3-yl)+, 100%]; elemental analysis calcd (%) for C60H94O2: C
85.04, H 11.18; found: C 84.88, H 11.21.
2.5.8.4. Dicholesteryl disulfide (23). White crystals; mp 104–107 °C
12%) and 3b-O-(10,20:30,40-di-O-isopropylidene-
a-D-galactopyr-
(hexane/AcOEt); Rf = 0.38 (hexane); IR,
m
max: 1110, 648, 517, 508;
anos-60-yl)-cholest-5-ene (17; 101 mg, 54%), followed by choles-
terol (1; 6 mg, 5%) eluted with hexane–ethyl acetate (9:1).
Other electrochemical reactions with different cholesteryl
donors were carried out in a similar manner.
1H NMR, d: 5.38 (m, 2H, H-6), 2.62 (m, 2H, H-3
a
), 1.01 (s, 6H, H-
19), 0.93 (d, 6H, J = 6.5 Hz, H-21), 0.879 (d, 6H, J = 6.6 Hz, H-26 or
H-27), 0.874 (d, 6H, J = 6.6 Hz, H-26 or H-27), 0.69 (s, 6H, H-18);
13C NMR (ppm), d: 141.7 (C), 121.2 (CH), 56.8 (CH), 56.2 (CH),
50.7 (CH), 50.3 (CH), 42.3 (C), 39.8 (CH2), 39.6 (CH2), 39.5 (CH2),
39.1 (CH2), 36.8 (C), 36.2 (CH2), 35.8 (CH), 31.90 (CH2), 31.85
(CH), 29.1 (CH2), 28.2 (CH2), 28.0 (CH), 24.3 (CH2), 23.8 (CH2),
22.8 (CH3), 22.6 (CH3), 21.0 (CH2), 19.3 (CH3), 18.7 (CH3), 11.9
(CH3); EI MS, m/z: 803 [(M+H)+, <1%], 369 [(cholest-5-en-3-yl)+,
100%]; elemental analysis calcd (%) for C54H90S2: C 80.73, H
11.29, S 7.98; found: C 80.69, H 11.32, S 7.96.
2.2.8. Other products of electrochemical reactions
2.2.8.1. 3,4-O-isopropylidene-2-O-[1-methyl-1-(cholest-5-en-3b-yl-
sulfanyl)-ethyl]-1-(cholest-5-en-3b-yl-sulfanyl)-b-
D
-galactopyranose
max: 3482,
(22). White solid; Rf = 0.37 (hexane-AcOEt 8:2); IR,
m
1242, 1161, 1059; 1H NMR (ppm), d: 5.32 (m, 2H, H-6), 3.38 (dd,
J1 = 7.3 Hz, J2 = 1.2 Hz, 1H, H-20), 4.23 (d, 1H, J = 1.3 Hz, H-10), 4.10
(m, 2H, H-30, H-50), 3.81 (m, 3H, H-40, H-60), 2.82 (m, 2H, H-3
a),
1.48 (s, 3H, H-isopropylidene), 1.43 (s, 6H, H-isopropylidene),
1.41 (s, 3H, H-isopropylidene), 1.022 (s, 3H, H-19), 1.017 (s, 3H,
H-19), 0.93 (d, 6H, J = 6.4 Hz, H-21), 0.881 (d, 6H, J = 6.6 Hz, H-26
or H-27), 0.874 (d, 6H, J = 6.6 Hz, H-26 or H-27), 0.69 (s, 6H, H-
18); 13C NMR (ppm), d: 142.0 (C), 141.7 (C), 120.9 (CH), 110.8
3. Results and discussion
As has been shown in our previous paper [19], anodic oxidation
of cholesterol (1) in the presence of a proper sugar affords